德甲诱导的MerTK+/高M2c巨细胞表现出对下调基因表达特征的偏好
Zhen-Tao Lee1,2, Farrah Putri Salmanida1,2, Hso-Chi Chaung2,3
1Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan.
Journal of genomics
|April 10, 2025
概括
德克萨米他诱导的M2c巨体显示出采用细胞疗法的潜力. 它们低调的基因表达支持免疫耐受性,并可能治疗自身免疫性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 文字转录学 (Transcriptomics) 是一个学科.
背景情况:
- 之前的研究表明,德克萨米他 (DEX) 诱导的M2c巨体表达MerTK受体减轻了全移植排斥.
- 关于采用M2c细胞的特性和更广泛的应用的研究有限.
研究的目的:
- 描述DEX诱导的MerTK+/高M2c巨细胞的转录组概况.
- 探索它们在自身免疫性疾病中采用细胞治疗的潜力.
主要方法:
- 对DEX诱导的MerTK+/高M2c巨细胞的转录组分析.
- 不同基因表达分析.
- 基格路径分析.
主要成果:
- 从上调调的基因中没有发现任何显著的途径.
- 下调的基因促进了KEGG的构建,突出了免疫耐受性作用.
- T细胞激活,细胞因子调节,白细胞招募和MHC-I/II蛋白质的表达减少.
结论:
- 由DEX诱导的MerTK+/高M2c巨体表现出下调的基因表达特征,表明具有免疫抑制性质.
- 这些巨细胞显示出在诸如类风湿性关节炎,炎症性肠病和I型糖尿病等自身免疫性疾病中采用细胞疗法的潜力.
- 进一步的研究可能会探索它们在糖尿病并发症中AGE/RAGE信号通路中的作用.
相关概念视频
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
GPCR Desensitization
5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K


